{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:44:16Z","timestamp":1785901456289,"version":"3.56.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Anestesiolog\u00eda y Reanimaci\u00f3n (English Edition)"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.redare.2026.502165","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:36:49Z","timestamp":1781739409000},"page":"502165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic monitoring of beta-lactams in critically ill patients with sepsis: Clinical trial protocol"],"prefix":"10.1016","volume":"73","author":[{"given":"I.","family":"Varela-Rey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"D\u00edaz-Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0183-1098","authenticated-orcid":false,"given":"M.\u00c1.","family":"G\u00f3mez-R\u00edos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10219","key":"10.1016\/j.redare.2026.502165_bib0005","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.redare.2026.502165_bib0010","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy313","article-title":"Sepsis in Intensive Care Unit patients: worldwide data from the intensive care over nations audit","volume":"5","author":"Sakr","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"10.1016\/j.redare.2026.502165_bib0015","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.redare.2026.502165_bib0020","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00134-010-2102-3","article-title":"Cost-effectiveness of the Surviving Sepsis Campaign protocol for severe Sepsis: a prospective nation-wide study in Spain","volume":"37","author":"Suarez","year":"2011","journal-title":"Intensive Care Med"},{"issue":"12","key":"10.1016\/j.redare.2026.502165_bib0025","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1097\/CCM.0000000000003342","article-title":"Epidemiology and costs of sepsis in the United States-an analysis based on timing of diagnosis and severity level","volume":"46","author":"Paoli","year":"2018","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.redare.2026.502165_bib0030","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/CCM.0b013e318232db65","article-title":"Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007","volume":"40","author":"Lagu","year":"2012","journal-title":"Crit Care Med"},{"issue":"8","key":"10.1016\/j.redare.2026.502165_bib0035","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/cid\/ciu027","article-title":"DALI: defining antibiotic levels in intensive care unit patients: are current \u03b2-lactam antibiotic doses sufficient for critically ill patients?","volume":"58","author":"Roberts","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.redare.2026.502165_bib0040","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ijantimicag.2010.06.008","article-title":"Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept","volume":"36","author":"Roberts","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"10459","key":"10.1016\/j.redare.2026.502165_bib0045","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050","volume":"404","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.redare.2026.502165_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coph.2015.06.002","article-title":"Augmented renal clearance in critically ill patients: etiology, definition and implications for beta-lactam dose optimization","volume":"24","author":"Sime","year":"2015","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"10.1016\/j.redare.2026.502165_bib0055","first-page":"87","article-title":"Pharmacokinetic variability of beta-lactams in critically ill patients: a narrative review","volume":"39","author":"Boidin","year":"2020","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"5","key":"10.1016\/j.redare.2026.502165_bib0060","article-title":"Beta-lactam dose optimisation in the intensive care unit: targets, therapeutic drug monitoring and toxicity","volume":"12","author":"Legg","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"7","key":"10.1016\/j.redare.2026.502165_bib0065","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9071505","article-title":"Beta-lactams toxicity in the intensive care unit: an underestimated collateral damage?","volume":"9","author":"Roger","year":"2021","journal-title":"Microorganisms"},{"issue":"8","key":"10.1016\/j.redare.2026.502165_bib0070","article-title":"A proof of concept of the usefulness of a TDM-guided strategy for optimizing Pharmacokinetic\/pharmacodynamic target of continuous infusion ampicillin-based regimens in a case series of patients with enterococcal bloodstream infections and\/or endocarditis","volume":"11","author":"Gatti","year":"2022","journal-title":"Antibiotics (Basel)"},{"issue":"6","key":"10.1016\/j.redare.2026.502165_bib0075","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","article-title":"Antimicrobial therapeutic drug monitoring in critically ill adult patients: a position paper","volume":"46","author":"Abdul-Aziz","year":"2020","journal-title":"Intensive Care Med"},{"issue":"8","key":"10.1016\/j.redare.2026.502165_bib0080","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.redare.2026.502165_bib0085","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13054-019-2378-9","volume":"23","author":"Guilhaumou","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.redare.2026.502165_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2024.154828","article-title":"Determinants of beta-lactam PK\/PD target attainment in critically ill patients: a single center retrospective study","volume":"83","author":"Gand\u00e9ga","year":"2024","journal-title":"J Crit Care"},{"issue":"11","key":"10.1016\/j.redare.2026.502165_bib0095","article-title":"Assessment of a PK\/PD target of continuous infusion Beta-lactams useful for preventing microbiological failure and\/or resistance development in critically ill patients affected by documented Gram-negative infections","volume":"10","author":"Gatti","year":"2021","journal-title":"Antibiotics (Basel)"},{"issue":"3","key":"10.1016\/j.redare.2026.502165_bib0100","article-title":"Predictive factors of piperacillin exposure and the impact on target attainment after continuous infusion administration to critically ill patients","volume":"12","author":"Mart\u00ednez-Casanova","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"6","key":"10.1016\/j.redare.2026.502165_bib0105","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s15010-019-01352-z","article-title":"Therapeutic drug monitoring-guided continuous infusion of piperacillin\/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a retrospective analysis of four years of clinical experience","volume":"47","author":"Richter","year":"2019","journal-title":"Infection"},{"issue":"3","key":"10.1016\/j.redare.2026.502165_bib0110","article-title":"Therapeutic drug monitoring of meropenem and piperacillin in critical illness-experience and recommendations from one year in routine clinical practice","volume":"9","author":"Scharf","year":"2020","journal-title":"Antibiotics (Basel)"},{"issue":"10","key":"10.1016\/j.redare.2026.502165_bib0115","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1093\/jac\/dkaa267","article-title":"Real-time TDM-based optimization of continuous-infusion meropenem for improving treatment outcome of febrile neutropenia in oncohaematological patients: results from a prospective, monocentric, interventional study","volume":"75","author":"Cojutti","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.redare.2026.502165_bib0120","series-title":"Antibiotics in Serum\/Plasma \u2013 HPLC (Order No. 61000)","author":"Chromsystems","year":"2026"},{"issue":"10","key":"10.1016\/j.redare.2026.502165_bib0125","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1128\/AAC.00533-11","article-title":"Simultaneous determination of 12 beta-lactam antibiotics in human plasma by high-performance liquid chromatography with UV detection: application to therapeutic drug monitoring","volume":"55","author":"Verdier","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"1-2","key":"10.1016\/j.redare.2026.502165_bib0130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jchromb.2008.01.037","article-title":"Simultaneous determination of five beta-lactam antibiotics (cefepim, ceftazidim, cefuroxim, meropenem and piperacillin) in human plasma by high-performance liquid chromatography with ultraviolet detection","volume":"864","author":"Denooz","year":"2008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"Pt 1","key":"10.1016\/j.redare.2026.502165_bib0135","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/0004563214557678","article-title":"Liquid chromatography tandem mass spectrometry in the clinical laboratory","volume":"52","author":"Adaway","year":"2015","journal-title":"Ann Clin Biochem"}],"container-title":["Revista Espa\u00f1ola de Anestesiolog\u00eda y Reanimaci\u00f3n (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341192926001423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341192926001423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:47:31Z","timestamp":1785898051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2341192926001423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2341192926001423"],"URL":"https:\/\/doi.org\/10.1016\/j.redare.2026.502165","relation":{},"ISSN":["2341-1929"],"issn-type":[{"value":"2341-1929","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic monitoring of beta-lactams in critically ill patients with sepsis: Clinical trial protocol","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Anestesiolog\u00eda y Reanimaci\u00f3n (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redare.2026.502165","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.redar.2026.502165","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de Anestesiolog\u00eda, Reanimaci\u00f3n y Terap\u00e9utica del Dolor. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"502165"}}